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ty and speciﬁcity we selected three targets including aggR,
VD432 and astA. The EAEC plasmid gene regulator, aggR
as 27.5—82% EAEC detection rate. The antiaggregation pro-
ein transporter gene, CVD432 (now aat), has a sensitivity of
5—89% and speciﬁcity of 99%. The enteroaggregative heat-
table enterotoxin gene astA has been reported in 29.8—44%
AEC strains and is most frequently detected among atypical
AEC.
Methods: Multiplex PCR was established for three genes
ggR(254 bp), CVD432(194 bp) and astAgene(94 bp). Antimi-
robial susceptibility was performed on the conﬁrmed
solates by Kirby Bauer method as recommended by CLSI.
Results: Out of a total of 185 isolates of E.coli 29%
53/185) showed presence of Enteroaggregative E.coli. Vir-
lence gene such as aggR was present in 69.8% (37/53)
solates. Genes such as east were positive in 43.3% (23/53)
f isolates and CVD was present in 56.6% (30/53) of iso-
ates.Majority of the strains were resistant to most ﬁrst line
ntibiotics showing high resistance for cotrimoxazole(84%),
moxycillin(81%) and norﬂoxacin(77%).
Conclusion: Diarrhoeagenic E.coli is a well established
ause of signiﬁcant morbidity and mortality worldwide. The
dentiﬁcation of EAEC by conventional techniques is techni-
ally demanding and time consuming. Multiplex PCR assays
argeting various virulence genes of EAEC can easily be
dopted for the routine diagnosis. In our study, 29% of cases
ere found to be caused by EAEC which were conﬁrmed
y multiplex PCR. Such a rapid technique can be extremely
seful in investigation of acute diarrhoea outbreaks due to
AEC. Drug resistance in EAEC is an increasing cause of con-
ern and most of isolates were resistant to all ﬁrst line
ntibiotics.
oi:10.1016/j.ijid.2010.02.1975
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henotypic and molecular characterization of Pseu-
omonas aeruginosa isolates expressing high-level beta-
actamic resistance in cystic ﬁbrosis patients
.D.C. Batlle ∗, J. Ayala
Academy of Sciences, Havana, Cuba
Background: Most cystic ﬁbrosis (CF) patients suffers
rom chronic and fatal pulmonary infections caused by
trains of Pseudomonas aeruginosa (Ps. aeruginosa). Resis-
ance to extended spectrum Cephalosporin in this pathogen
s associated in most cases with the over production
f Cephalosporinase. The b-lactamases of Ps. aeruginosa
estroy antimicrobials with: carboxipenicilin, aminopeni-
ilin and cephalosporin The purpose of this study was to
etermine the presence of b lactamases genes (bla pse–
, ampC and bla oxa) in strains resistant. The nucleotide
equences by theses gene were determined in three resis-
ant strains to beta lactam antibiotic.
Methods: In our study 65 Ps. aeruginosa isolations were
btained from 15 cystic pediatric patients attending in
illiam Soler, in Havana during ﬁve years. Were character-zed by Micro dilution broth (MIC), Api System, Phagotyping
nd serotyping and Pulse Field gel Electrophoresis. High
evel Ceftazidime resistant isolate were conﬁrmed by PCR
etection of bla pse–1, ampC and bla oxa gene. Ampliconsternational Congress on Infectious Diseases (ICID) Abstracts
esulting from PCR determining regions of these genes were
uriﬁed with a Quia Quick spin PCR puriﬁcation kit. The
ucleotide sequences were determined with an automatic
equencer ABI PRISM 377 DNA SECUENCER.
Results: Mutations in the beta lactam resistance deter-
ining region of the ampC gene were detected in 3 strains
eftazidime resistant. Higth level by MIC to Ticarcillin,
ztreonam and Ceftazidime was associated with mutations
t codon 180 and 195 of the AmpC gene. The codon 180
mino acid change Pro to Arg and the codon 195 the
minoacid change Glu to Lys in the three strains. The
pidemiological date indicated that such resistant strains
robably emerge independently, possibly following selection
uring treatment with beta lactam drug.
Conclusion: Two main clusters were detected by PFGE
n our study, with common clonal relation among strains
iperacillin, Tobramicin and Meropenem were active against
ost of the strains tested, and is a good choice of antibac-
erial drug for treating CF infections. The results this work
ill be very helpful to guide empirical antimicrobial therapy
nd the implementation of infection control in cystic ﬁbrosis
atients in our country.
oi:10.1016/j.ijid.2010.02.1976
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pigenetic regulation of lymphocytes response to LPS
. Melo1,∗, M. Camargo2, R. Curi 2, I. Velasco1, F. Soriano1
Medicine school University of Sao Paulo, Sao Paulo, Sao
AULO, Brazil
ICB University of Sao Paulo, Sao Paulo, Sao PAULO, Brazil
Background: Recent evidence suggests that many inﬂam-
atory genes are regulated by epigenetic modiﬁcations to
ndividual promoters. This level of control allows a single
ene to be expressed or silenced according to its func-
ion and to the previous conditions suffered, irrespective
f other genes induced by the same receptor, and therefore
s ‘‘gene-speciﬁc’’. The aim of the study is analyze in LPS
olerance the epigenetic via used to regulate gene expres-
ion (demethylation or hypermethylation) in lymphocytes
esponse.
Methods: Lymphocytes were cultured in DMEM (con-
rol C). Tolerance was reproduced in culture lymphocytes
xposed to LPS (T group) (24 and 48 h). NAB or 5aza were
dded once (NAB1 and 5aza1) for 24 h. After this period
PS was added to the media. The production of IL-6, IL-
0, IL-1, TNF, and MIP-2 were measured by enzyme-linked
mmunosorbent assay (ELISA). RT-PCR was performed to ver-
fy the differential mRNA expression. Primer sequences were
esigned using GenBank (www.ncbi.nlm.nih.gov).
tracts e221
AB1 NAB2 AZA1 AZA2
1000 pg/ml* ±1000 pg/ml# ±2000 pg/ml& ±10000 pg/ml$
4000 pg/ml ±5000 pg/ml ±4000 pg/ml& ±2000 pg/ml$
3000 pg/ml ±5000 pg/ml ±4000 pg/ml ±1000 pg/ml$
3000 pg/ml* ±6000 pg/ml ±4500 pg/ml& ±3000 pg/ml$
1500 pg/ml* ±4000 pg/ml ±1500 pg/ml& ±4500 pg/ml
8900† ±70000‡ ±20000 ±71000
3000 ±4500 ±5300 ±60004
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Results: Control LPS high dose Tolerant N
ELISA
TNF ±500 pg/ml ±20000 pg/ml ±1000 pg/ml ±
MIP ±50 pg/ml ±3000 pg/ml ±100 pg/ml ±
IL-1 ±70 pg/ml ±6000 pg/ml ±200 pg/ml ±
IL-6 ±58 pg/ml ±9000 pg/ml ±40 pg/ml ±
IL-10 ±50 pg/ml ±2000 pg/ml ±100 pg/ml ±
RT-PCR
TNF ±100 ±40000 ±1000 ±
IL-1 ±150 ±30000 ±2500 ±
ELISA
NAB1, * p < 0.05 compared to NAB2
NAB2, # p < 0.05 compared to LPS high dose
AZ1 & p< 0.05 compared to AZ2
AZ2, $ p < 0.05 compared to LPS high dose
RT-PCR
NAB1, † p < 0.05 compared to NAB2
NAB2, ‡p < 0.05 compared to LPS high dose
AZ2, 4 p < 0.05 compared to LPS high dose
Results are expressed as means± SEM. Comparisons among the group
were performed by using paired t-test.
Conclusion: Tolerance is regulating the expression of the
inﬂammatory genes differentially: 1-the epigenetic mech-
anism involved in regulating the expression of the genes:
MIP2 and IL1 is the demethylation of histones, 2- however,
the epigenetic regulation of IL6 and IL10 is through hyperme-
thylation and 3-the gene: TNF is regulated by demethylation
and hypermethylation.
doi:10.1016/j.ijid.2010.02.1977
52.020
Clinical and phylogenetic characteristics of Escherichia
coli urinary tract infections
S.Y. Lee ∗, J.H. Kim, J.K. Hur, J.H. Kang
The Catholic university of Korea, Seoul, Korea, Republic of
Background: We aimed to investigate the clinical and
phylogenetic characteristics of Escherichia coli Urinary Tract
Infections (E. coli UTI).
Methods: We enrolled patients with culture-proven E.
coli UTI, who were admitted at the study hospital from
September 2008 to August 2009. We investigated clinical
data of patients with E. coli UTI and characteristics of iso-
lated E. coli strains. The phylogenetic groups were classiﬁed
using triplex polymerase chain reaction (PCR), and the dis-
tribution of nine virulent genes was determined by multiplex
PCR.
Results: A total of 47 patients have participated in this
study. Thirty (63.8%) were under 6 months; eight (17.0%)
were between 6-12 months; and nine (19.1%) were over 12
months. We compared two age groups between under 6-
month and over 6-month. In the age group under 6-month,
higher proportion of male (P = 0.002) and group B2 strains
(P = 0.020) were observed. In contrast, higher proportion of
female and group non-B2 strains were observed in age group
over 6-month. In the comparison of phylogenetic groups,
group B2 showed higher distribution of virulent genes,
while group D included more strains resistant to trimetho-
prim/sulfamethoxazole (TMP/SMZ) than other groups.
C
S
1
3Conclusion: We showed the age group-speciﬁc difference
n the distribution of phylogenetic groups; more male and
roup B2 strains in age group under 6-month, while more
emale and group non-B2 in age group over 6-month. How-
ver, further evaluation including larger number of patients
ill be necessary to conﬁrm above thesis in future molecular
pidemiological studies.
oi:10.1016/j.ijid.2010.02.1978
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School of Medicine, National University of La Plata and
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uenos Aires, Argentina
Background: Meningococcal invasive disease (MID) is
ndemic/ hyperendemic/ epidemic at La Plata city, Buenos
ires, Argentina and its surrounding areas. First isolation
f N. meningitids W135 (NmW135) in Argentina was made
n 1981 in this location and, since then, sporadic cases
ccurred. MID is a rare disease in persons older than 15 years
f age in our country. The aim of this study is to describe
he clinical presentation, age group and fatality rate for
mW135 MID.
Methods: We prospectively studied 707 inpatients with
ID in a 13-year period; children accounted for 99.4%
n = 703). Blood and CSF cultures and isolation were made
y standard methods, identiﬁcation with DIFCO serum, and
or the last three years PCR gen (crgA) by M. Taha method (J
lin Microbiol 2000; 38:855-857) at Microbiology Laboratory,
or María Ludovica Childrenˇıs Hospital, La Plata, Argentina.
Results: First period (1996-2001): 419 MID total cases and
.2% (n = 5) were caused by NmW135. Age group (range):
months-9 years old. Clinical presentation: sepsis and
